-
1
-
-
0033928865
-
Epidemiology of actinic keratoses and squamous cell carcinoma
-
Salasche SJ,. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42 (1 Pt 2): 4-7.
-
(2000)
J Am Acad Dermatol
, vol.42
, Issue.1 PART 2
, pp. 4-7
-
-
Salasche, S.J.1
-
3
-
-
0033940686
-
Clinical presentation of actinic keratoses and squamous cell carcinoma
-
Moy RL,. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42 (1 Pt 2): 8-10.
-
(2000)
J Am Acad Dermatol
, vol.42
, Issue.1 PART 2
, pp. 8-10
-
-
Moy, R.L.1
-
4
-
-
33745010916
-
Solar (actinic) keratosis is squamous cell carcinoma
-
DOI 10.1111/j.1365-2133.2005.07121.x
-
Ackerman AB, Mones JM,. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22. (Pubitemid 43876387)
-
(2006)
British Journal of Dermatology
, vol.155
, Issue.1
, pp. 9-22
-
-
Ackerman, A.B.1
Mones, J.M.2
-
5
-
-
0035097541
-
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis
-
Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumour angiogenesis and metastasis. Neoplasia 2001; 3: 53-61. (Pubitemid 32201610)
-
(2001)
Neoplasia
, vol.3
, Issue.1
, pp. 53-61
-
-
Gallo, O.1
Franchi, A.2
Magnelli, L.3
Sardi, I.4
Vannacci, A.5
Boddi, V.6
Chiarugi, V.7
Masini, E.8
-
6
-
-
29244449354
-
Prostaglandins and cancer
-
DOI 10.1136/gut.2004.047100
-
Wang D, Dubois RN,. Prostaglandins and cancer. Gut 2006; 55: 115-122. (Pubitemid 41820645)
-
(2006)
Gut
, vol.55
, Issue.1
, pp. 115-122
-
-
Wang, D.1
Dubois, R.N.2
-
7
-
-
0036140937
-
Diclofenac antagonizes peroxisome proliferator-activated receptor-γ signaling
-
DOI 10.1124/mol.61.1.7
-
Adamson DJ, Frew D, Tatoud R, et al. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling. Mol Pharmacol 2002; 61: 7-12. (Pubitemid 34049506)
-
(2002)
Molecular Pharmacology
, vol.61
, Issue.1
, pp. 7-12
-
-
Adamson, D.J.A.1
Frew, D.2
Tatoud, R.3
Roland Wolf, C.4
Palmer, C.N.A.5
-
8
-
-
34247385565
-
Apoptosis pathways as promising targets for skin cancer therapy
-
DOI 10.1111/j.1365-2133.2007.07855.x
-
Eberle J, Fecker LF, Forschner T, Ulrich C, Rowert-Huber J, Stockfleth E,. Apoptosis pathways as promising targets for skin cancer therapy. Br J Dermatol 2007; 156 (Suppl. 3): 18-24. (Pubitemid 46632507)
-
(2007)
British Journal of Dermatology
, vol.156
, Issue.SUPPL. 3
, pp. 18-24
-
-
Eberle, J.1
Fecker, L.F.2
Forschner, T.3
Ulrich, C.4
Rowert-Huber, J.5
Stockfleth, E.6
-
9
-
-
34247333077
-
The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)
-
DOI 10.1111/j.1365-2133.2007.07856.x
-
Fecker LF, Stockfleth E, Nindl I, et al. The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol 2007; 156 (Suppl. 3): 25-33. (Pubitemid 46632508)
-
(2007)
British Journal of Dermatology
, vol.156
, Issue.SUPPL. 3
, pp. 25-33
-
-
Fecker, L.F.1
Stockfleth, E.2
Nindl, I.3
Ulrich, C.4
Forschner, T.5
Eberle, J.6
-
10
-
-
18844423259
-
Hyaluronic acid: A unique topical vehicle for the localized delivery of drugs to the skin
-
DOI 10.1111/j.1468-3083.2004.01180.x
-
Brown MB, Jones SA,. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol 2005; 19: 308-318. (Pubitemid 40691707)
-
(2005)
Journal of the European Academy of Dermatology and Venereology
, vol.19
, Issue.3
, pp. 308-318
-
-
Brown, M.B.1
Jones, S.A.2
-
11
-
-
0029070913
-
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation
-
Hall CL, Yang B, Yang X, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995; 82: 19-26.
-
(1995)
Cell
, vol.82
, pp. 19-26
-
-
Hall, C.L.1
Yang, B.2
Yang, X.3
-
12
-
-
0028090359
-
Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan
-
McCourt PA, Ek B, Forsberg N, et al. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 1994; 269: 30081-30084. (Pubitemid 24376465)
-
(1994)
Journal of Biological Chemistry
, vol.269
, Issue.48
, pp. 30081-30084
-
-
McCourt, P.A.G.1
Ek, B.2
Forsberg, N.3
Gustafson, S.4
-
13
-
-
0035659622
-
Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
-
DOI 10.1046/j.1365-4362.2001.01324.x
-
Wolf JE Jr, Taylor JR, Tschen E, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40: 709-713. (Pubitemid 34023642)
-
(2001)
International Journal of Dermatology
, vol.40
, Issue.11
, pp. 709-713
-
-
Wolf Jr., J.E.1
Taylor, J.R.2
Tschen, E.3
Kang, S.4
-
14
-
-
0030841385
-
An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% Hyaluronic acid gel for the treatment of actinic keratoses
-
Rivers JK, McLean DI,. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol 1997; 133: 1239-1242. (Pubitemid 27443816)
-
(1997)
Archives of Dermatology
, vol.133
, Issue.10
, pp. 1239-1242
-
-
Rivers, J.K.1
McLean, D.I.2
-
15
-
-
0037325491
-
Topical diclofenac in hyaluronan gel for the treatment of solar keratoses
-
DOI 10.1046/j.1440-0960.2002.00635.x
-
Gebauer K, Brown P, Varigos G,. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol 2003; 44: 40-43. (Pubitemid 36246421)
-
(2003)
Australasian Journal of Dermatology
, vol.44
, Issue.1
, pp. 40-43
-
-
Gebauer, K.1
Brown, P.2
Varigos, G.3
-
16
-
-
7644224775
-
Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze)
-
Nelson C, Rigel D, Smith S, et al. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol 2004; 3: 401-407.
-
(2004)
J Drugs Dermatol
, vol.3
, pp. 401-407
-
-
Nelson, C.1
Rigel, D.2
Smith, S.3
-
17
-
-
0036178561
-
Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel
-
DOI 10.1046/j.1365-2133.2002.04561.x
-
Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 146: 94-100. (Pubitemid 34158414)
-
(2002)
British Journal of Dermatology
, vol.146
, Issue.1
, pp. 94-100
-
-
Rivers, J.K.1
Arlette, J.2
Shear, N.3
Guenther, L.4
Carey, W.5
Poulin, Y.6
-
18
-
-
33646204466
-
Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp
-
Smith SR, Morhenn VB, Piacquadio DJ,. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol 2006; 5: 156-159.
-
(2006)
J Drugs Dermatol
, vol.5
, pp. 156-159
-
-
Smith, S.R.1
Morhenn, V.B.2
Piacquadio, D.J.3
-
20
-
-
27744503544
-
Translating the science of quality of life into practice: What do dermatology life quality index scores mean?
-
Hongbo Y, Thomas CL, Harrison MA, et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
-
(2005)
J Invest Dermatol
, vol.125
, pp. 659-664
-
-
Hongbo, Y.1
Thomas, C.L.2
Harrison, M.A.3
-
21
-
-
34247376606
-
Actinic keratosis is an early in situ squamous cell carcinoma: A proposal for reclassification
-
DOI 10.1111/j.1365-2133.2007.07860.x
-
Rowert-Huber J, Patel MJ, Forschner T, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156 (Suppl. 3): 8-12. (Pubitemid 46632512)
-
(2007)
British Journal of Dermatology
, vol.156
, Issue.SUPPL. 3
, pp. 8-12
-
-
Rowert-Huber, J.1
Patel, M.J.2
Forschner, T.3
Ulrich, C.4
Eberle, J.5
Kerl, H.6
Sterry, W.7
Stockfleth, E.8
-
22
-
-
0033928866
-
Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis")
-
Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42 (1 Pt 2): 11-17.
-
(2000)
J Am Acad Dermatol
, vol.42
, Issue.1 PART 2
, pp. 11-17
-
-
Cockerell, C.J.1
-
23
-
-
76349101673
-
Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses
-
Dirschka T, Bierhoff E, Pflugfelder A, et al. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses. J Eur Acad Dermatol Venereol 2010; 24: 258-263.
-
(2010)
J Eur Acad Dermatol Venereol
, vol.24
, pp. 258-263
-
-
Dirschka, T.1
Bierhoff, E.2
Pflugfelder, A.3
-
24
-
-
57749206167
-
Development of a treatment algorithm for actinic keratoses: A European Consensus
-
Stockfleth E, Ferrandiz C, Grob JJ, et al. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-659.
-
(2008)
Eur J Dermatol
, vol.18
, pp. 651-659
-
-
Stockfleth, E.1
Ferrandiz, C.2
Grob, J.J.3
|